跳至主要内容
临床试验/CTRI/2025/01/079492
CTRI/2025/01/079492尚未招募2/3 期

A Clinical study to evaluate the efficacy of Niruha Basti alongwith Shamana Chikitsa in management of Chronic kidney disease - A single group pre-and post-design clinical study

J S Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Primary outcome will be relief in signs, symptoms and assessment will be done with the help of changes in Hb eGFR Serum Creatinine Blood Urea Serum Electrolytes (Sodium, Potassium, Chloride) Serum Calcium Serum Phosphate Urine Routine and Microscopic

研究概览

简要总结

Clinical evaluation of Ayurvedic management of Chronic kidney disease is the main objective of the study.

Patients will be selected from P.D. Patel Ayurvedic Hospital, Nadiad after the confirmation of the patients of the Chronic kidney disease with the help of classical signs and symptoms, they will be treated with following therapy:

  1. Punarnavadi Niruha Basti

  2. Shamana Chikitsa

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients fulfilling the diagnostic criteria.
  • 2.Patients having age between 18 to 65 years.
  • 3.Patients with GFR level less than 60 ml/min/1.73 meter square and persistent (present for more than 3 months), laboratory investigations (i.e. raised serum creatinine and blood urea level).

排除标准

  • 1.Female patients having pregnancy, breast feeding or post-delivery period.
  • 2.Patients of end stage kidney disease.
  • 3.Patients who are on dialysis treatment.
  • 4.Patients who are having previous history of renal transplantation.
  • 5.Patients of hepato-renal insufficiency or renal insufficiency due to hemodynamic circulatory disorders and CCF.
  • 6.Patients having comorbidities like cardio- vascular diseases, psychological disorders, serious acute organic diseases, liver disorders or metabolic disorders etc.
  • 8.Patients on steroid medications.

结局指标

主要结局

Primary outcome will be relief in signs, symptoms and assessment will be done with the help of changes in Hb eGFR Serum Creatinine Blood Urea Serum Electrolytes (Sodium, Potassium, Chloride) Serum Calcium Serum Phosphate Urine Routine and Microscopic

时间窗: Baseline, 2 weeks and 4 weeks after discharge

次要结局

未报告次要终点

研究者

发起方
J S Ayurveda Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Khushaboo Kuldeepsingh Chauhan

J.S. Ayurveda Mahavidyalaya and P.D. Patel Ayurveda Hospital

研究点 (1)

Loading locations...

相似试验